Author Interviews, Heart Disease, Rheumatology / 29.10.2013
Rheumatoid Arthritis: Heart Disease and Biologics
MedicalResearch.com Interview with:
Lotta Ljung, MD, PhD
Umeå University, Umeå and Karolinska Institute
Stockholm, Sweden
MedicalResearch.com: What are the main findings of the study?
Dr. Ljung: In this observational study we observed a lower risk of acute coronary syndromes in a cohort of patients with rheumatoid arthritis (RA) exposed to tumor necrosis factor inhibitors (TNFi) compared with the risk among patients without this exposure. The adjusted relative risk (HR) was 0.73-0.82 among TNFi exposed patients compared with the biologics-naive RA cohort, depending on the time frame evaluated, which can be concluded as a moderately lower risk.
Compared with the risk in the general population, the risk in RA patients was higher, whether exposed to TNFi or not.
(more…)